Pfizer to require U.S. workers receive COVID-19 vaccine or regular tests
Reuters
Published Aug 04, 2021 03:43PM ET
Updated Aug 04, 2021 04:30PM ET
By Michael Erman
NEW YORK (Reuters) -Pfizer Inc, the U.S. drugmaker that developed a COVID-19 vaccine with German partner BioNTech, said on Wednesday it will require all its U.S. employees and contractors to become vaccinated against COVID-19 or participate in weekly COVID-19 testing.
Pfizer (NYSE:PFE) spokesperson Pamela Eisele said the company was taking the initiative in order to "to protect the health and safety of our colleagues and the communities we serve." Employees with medical conditions or religious objections can seek accommodations.
Outside of the United States, Pfizer will strongly encourage employees who are able be vaccinated in their countries to do so, Eisele said.
At the end of 2020, Pfizer had around 29,400 U.S-based employees.
With U.S. coronavirus cases rising sharply again due to the highly transmissible Delta variant, companies like Alphabet (NASDAQ:GOOGL) Inc and Walt Disney (NYSE:DIS) Inc have started putting vaccine mandates in place for their employees.
As of Tuesday, 70.1% of U.S. adults had received at least one dose of a COVID-19 vaccine, according to data from the U.S. Centers for Disease Control and Prevention.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.